PEOPLE - Haemonetics makes appointment:
This article was originally published in Clinica
US automated blood processing systems developer Haemonetics has appointed Dr Harvey Klein and Colin Lind to its board of directors. Dr Klein is currently vice-president of the American Association of Blood Banks and Mr Lind is managing director of investment firm Richard C Blum & Associates.
You may also be interested in...
Scrip’s on-the-ground team in Asia talks about how the regional and wider pharma industry and policymakers have responded so far to the spreading coronavirus outbreak, with a focus on the expedited development of potential drugs and vaccines.
Oncologic Drugs Advisory Committee votes 6-5 that ramucirumab’s benefit/risk profile is favorable in first-line lung cancer, but 13-2 that pivotal trial data do not support approval of Steba’s vascular-targeted, photodynamic therapy for low-risk prostate cancer.